-DOCSTART- -X- O
Abstract -X- _ O
Recombinant -X- _ O
Salmonella -X- _ O
enterica -X- _ O
serovar -X- _ O
Typhi -X- _ O
can -X- _ O
function -X- _ O
as -X- _ O
a -X- _ O
live -X- _ O
vector -X- _ O
to -X- _ O
deliver -X- _ O
foreign -X- _ O
antigens -X- _ O
to -X- _ O
the -X- _ O
mammalian -X- _ O
immune -X- _ O
system -X- _ O
and -X- _ O
induce -X- _ O
both -X- _ O
mucosal -X- _ O
and -X- _ O
systemic -X- _ O
immunity. -X- _ O
In -X- _ O
this -X- _ O
study -X- _ O
, -X- _ O
we -X- _ O
generated -X- _ O
a -X- _ O
recombinant -X- _ B-intervention
Salmonella -X- _ I-intervention
Typhi -X- _ I-intervention
strain -X- _ I-intervention
pilS− -X- _ I-intervention
pilT−Gag+ -X- _ I-intervention
( -X- _ I-intervention
pVAX1-gp120 -X- _ I-intervention
) -X- _ I-intervention
harboring -X- _ I-intervention
the -X- _ I-intervention
human -X- _ I-intervention
immunode -X- _ I-intervention
ciency -X- _ I-intervention
virus -X- _ I-intervention
( -X- _ I-intervention
HIV -X- _ I-intervention
) -X- _ I-intervention
gag -X- _ I-intervention
gene -X- _ I-intervention
integrated -X- _ O
into -X- _ O
the -X- _ O
bacterial -X- _ O
chromosome -X- _ O
and -X- _ O
gp120 -X- _ O
gene -X- _ O
carried -X- _ O
by -X- _ O
a -X- _ O
plasmid. -X- _ O
Mice -X- _ B-patient
inoculated -X- _ B-outcome
with -X- _ I-outcome
this -X- _ I-outcome
recombinant -X- _ I-outcome
bacterium -X- _ I-outcome
through -X- _ I-outcome
intranasal -X- _ I-outcome
route -X- _ I-outcome
produced -X- _ I-outcome
high -X- _ I-outcome
titers -X- _ I-outcome
of -X- _ I-outcome
IgG -X- _ I-outcome
to -X- _ I-outcome
gp120 -X- _ I-outcome
in -X- _ I-outcome
sera -X- _ I-outcome
and -X- _ I-outcome
IgA -X- _ I-outcome
to -X- _ I-outcome
gp120 -X- _ I-outcome
in -X- _ I-outcome
fecal -X- _ I-outcome
washes. -X- _ I-outcome
In -X- _ O
addition -X- _ O
, -X- _ O
Gag-speci -X- _ B-outcome
c -X- _ I-outcome
and -X- _ I-outcome
gp120-speci -X- _ I-outcome
c -X- _ I-outcome
cytotoxic -X- _ I-outcome
T -X- _ I-outcome
lymphocyte -X- _ I-outcome
( -X- _ I-outcome
CTL -X- _ I-outcome
) -X- _ I-outcome
responses -X- _ I-outcome
were -X- _ I-outcome
observed -X- _ I-outcome
in -X- _ I-outcome
sorted -X- _ I-outcome
spleen -X- _ I-outcome
lymphocytes -X- _ I-outcome
of -X- _ I-outcome
immunized -X- _ I-outcome
mice -X- _ I-outcome
. -X- _ O

These -X- _ O
results -X- _ O
demonstrated -X- _ O
that -X- _ O
this -X- _ O
recombinant -X- _ B-outcome
Salmonella -X- _ I-outcome
Typhi -X- _ I-outcome
strain -X- _ I-outcome
elicits -X- _ I-outcome
multiple -X- _ I-outcome
immune -X- _ I-outcome
responses -X- _ I-outcome
against -X- _ I-outcome
both -X- _ I-outcome
Gag -X- _ I-outcome
and -X- _ I-outcome
gp120 -X- _ I-outcome
antigens -X- _ I-outcome
of -X- _ I-outcome
HIV -X- _ I-outcome
, -X- _ O
and -X- _ O
thus -X- _ O
would -X- _ O
be -X- _ O
a -X- _ O
potential -X- _ O
vaccine -X- _ O
candidate -X- _ O
to -X- _ O
the -X- _ O
prevention -X- _ O
of -X- _ O
HIV -X- _ O
/ -X- _ O
AIDS -X- _ O
. -X- _ O

